Brind.

BrainsWay Ltd. provided a strategic investment to Neurolief, which is awaiting FDA approval for its drug Proliv™Rx.

1 report, 1 independent Updated Aug 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Brainsway Ltd.FDA

How it developed

Newest first. Tap a step to see who reported it.

Jun 7Brainsway Ltd. secured a strategic investment that is expected to expand its market reach.Sub-event
Aug 21Brainsway invested in Neurolief, which is seeking FDA approval for Proliv™Rx.1 source
- PR Newswire

Keep exploring

The entities involved

Brainsway Ltd.
Medical technology company

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Aug 21PR NewswireNeurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay CORAL SPRINGS, Fla. and NETANYA, Israel, Aug. 21, 2025 /PRNewswire/ -- Neu